全文获取类型
收费全文 | 4032篇 |
免费 | 241篇 |
国内免费 | 24篇 |
专业分类
耳鼻咽喉 | 28篇 |
儿科学 | 123篇 |
妇产科学 | 80篇 |
基础医学 | 535篇 |
口腔科学 | 127篇 |
临床医学 | 277篇 |
内科学 | 964篇 |
皮肤病学 | 56篇 |
神经病学 | 317篇 |
特种医学 | 114篇 |
外科学 | 704篇 |
综合类 | 26篇 |
预防医学 | 329篇 |
眼科学 | 61篇 |
药学 | 208篇 |
中国医学 | 27篇 |
肿瘤学 | 321篇 |
出版年
2023年 | 29篇 |
2022年 | 71篇 |
2021年 | 131篇 |
2020年 | 79篇 |
2019年 | 117篇 |
2018年 | 138篇 |
2017年 | 78篇 |
2016年 | 96篇 |
2015年 | 124篇 |
2014年 | 149篇 |
2013年 | 192篇 |
2012年 | 333篇 |
2011年 | 315篇 |
2010年 | 185篇 |
2009年 | 138篇 |
2008年 | 263篇 |
2007年 | 283篇 |
2006年 | 256篇 |
2005年 | 219篇 |
2004年 | 201篇 |
2003年 | 242篇 |
2002年 | 224篇 |
2001年 | 37篇 |
2000年 | 20篇 |
1999年 | 30篇 |
1998年 | 27篇 |
1997年 | 19篇 |
1996年 | 24篇 |
1995年 | 16篇 |
1994年 | 15篇 |
1993年 | 16篇 |
1992年 | 23篇 |
1991年 | 15篇 |
1990年 | 17篇 |
1989年 | 17篇 |
1988年 | 18篇 |
1987年 | 12篇 |
1986年 | 16篇 |
1985年 | 10篇 |
1984年 | 11篇 |
1983年 | 5篇 |
1982年 | 16篇 |
1981年 | 8篇 |
1980年 | 5篇 |
1979年 | 3篇 |
1978年 | 7篇 |
1977年 | 3篇 |
1976年 | 9篇 |
1975年 | 7篇 |
1973年 | 4篇 |
排序方式: 共有4297条查询结果,搜索用时 0 毫秒
991.
Lourdes Mnica Bravo-Anaya Gabriel Landazuri Gmez Edgar Figueroa-Ochoa Francisco Carvajal Ramos J. Flix Armando Soltero Martínez Yahya Rharbi 《RSC advances》2018,8(69):39444
Vectorization has experienced significant development over the last few years and has been used to control the distribution of active ingredients to a target by their association with a vector. However, controlled drug delivery suffers from “burst release” as the drugs are released before the targeted site. Very few studies have examined the collective mechanisms of fission–fusion on micelles in the transport and expulsion of active ingredients. Endocytosis and exocytosis of cells are examples of fusion and fission in biological matter. Understanding these dynamics becomes crucial for the design and the control of new materials and new processes effective in controlled drug delivery. In this work, a study of the exchange dynamics between amphiphilic block copolymers and lipid membranes for vectorization of hydrophobic molecules using a fluorescence technique is presented. A highly hydrophobic alkylated pyrene, PyC18, is used as a fluorescent probe that can be exchanged between amphiphilic block copolymer micelles and liposomes via different mechanisms. It is demonstrated that the exchange dynamics evaluated for different liposome concentrations is a collective mechanism characterized by having two rate constants.Exchange dynamics between P104 micelles and liposomes for vectorization followed by using PyC18 hydrophobic probe. 相似文献
992.
Armando Gavazzi Francesca de Rino Maria Claudia Boveri Anna Picozzi Massimo Franceschi 《Neurological sciences》2016,37(2):205-209
We evaluated 374 consecutive patients from May 2013 to April 2014 who underwent major cardiac surgery. Each patient had an interview and a neurological clinical examination during the rehabilitation period. Patients with possible peripheral nervous system (PNS) complications underwent further electrodiagnostic tests. Among 374 patients undergoing major heart surgery (coronary artery bypass grafting, valvular heart surgery, ascending aortic aneurysm repair) 23 (6.1 %) developed 34 new PNS complications. We found four brachial plexopathies; four carpal tunnel syndromes; five critical illness neuropathies; three worsening of pre-existing neuropathies; two involvement of X, one of IX and one of XII cranial nerves; three peroneal (at knee), one saphenous, two median (at Struthers ligament), six ulnar (at elbow) mononeuropathies; two meralgia parestheticas. Diabetes is a strong risk factor for PNS complications (p = 0.002); we could not find any other relationship of PNS complications with clinical conditions, demographic data (gender, age) or type of surgical intervention. The mononeuropathies of right arms can be related to ipsilateral vein cannulation; position of body and stretching from chest wall retraction may be the cause of mononeuropathies of left arms (more frequent); the use of saphenous vein and position of the limbs may be the cause of mononeuropathies of the legs; surgical and anesthetical procedures can injure cranial nerves; respiratory failure and infection during the first days after surgery can cause critical illness neuropathies. Careful preoperative assessment and intraoperative management may reduce the risk of long-term PNS complications after cardiac surgery. 相似文献
993.
Edison Castro Maira R. Cern Andrea Hernandez Garcia Quentin Kim Alvaro Etcheverry-Berríos Mauricio J. Morel Raúl Díaz-Torres Wenjie Qian Zachary Martinez Lois Mendez Frank Perez Christy A. Santoyo Raquel Gimeno-Muoz Ronda Esper Denisse A. Gutierrez Armando Varela-Ramirez Renato J. Aguilera Manuel Llano Monica Soler Núria Aliaga-Alcalde Luis Echegoyen 《RSC advances》2019,9(5):2379
Correction for ‘A new family of fullerene derivatives: fullerene–curcumin conjugates for biological and photovoltaic applications’ by Edison Castro et al., RSC Adv., 2018, 8, 41692–41698.The authors regret that the following funding information was mistakenly omitted from the acknowledgements in the original article: “Research reported in this article was partially supported by the National Institute of General Medical Sciences of the National Institutes of Health under linked Award Numbers RL5GM118969, TL4GM118971, and UL1GM118970. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.”The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers. 相似文献
994.
995.
Additional Prognostic Value of EAS index in predicting the occurrence of rehospitalizations in chronic heart failure: data from the Daunia Heart Failure Registry 下载免费PDF全文
996.
Preliminary Report on the Outcome of Tilted Implants with Longer Lengths (20–25 mm) in Low‐Density Bone: One‐Year Follow‐Up of a Prospective Cohort Study 下载免费PDF全文
997.
The NobelGuide® All‐on‐4® Treatment Concept for Rehabilitation of Edentulous Jaws: A Prospective Report on Medium‐ and Long‐Term Outcomes 下载免费PDF全文
998.
999.
Armando Del Portillo Stephen M. Lagana Yuan Yao Takeshi Uehara Nirag Jhala Tapan Ganguly Peter Nagy Jorge Gutierrez Aesis Luna Julian Abrams Yang Liu Randall Brand Jorge L. Sepulveda Gary W. Falk Antonia R. Sepulveda 《The Journal of molecular diagnostics : JMD》2015,17(4):412-419
Barrett''s intestinal metaplasia (BIM) may harbor genomic mutations before the histologic appearance of dysplasia and cancer and requires frequent surveillance. We explored next-generation sequencing to detect mutations with the analytical sensitivity required to predict concurrent high-grade dysplasia (HGD) and esophageal adenocarcinoma (EAC) in patients with Barrett''s esophagus by testing nonneoplastic BIM. Formalin-fixed, paraffin-embedded (FFPE) routine biopsy or endoscopic mucosal resection samples from 32 patients were tested: nonprogressors to HGD or EAC (BIM-NP) with BIM, who never had a diagnosis of dysplasia or EAC (N = 13); progressors to HGD or EAC (BIM-P) with BIM and a worse diagnosis of HGD or EAC (N = 15); and four BIM-negative samples. No mutations were detected in the BIM-NP (0 of 13) or BIM-negative samples, whereas the BIM-P samples had mutations in 6 (75%) of 8 cases in TP53, APC, and CDKN2A (P = 0.0005), detected in samples with as low as 20% BIM. We found that next-generation sequencing from routine FFPE nonneoplastic Barrett''s esophagus samples can detect multiple mutations in minute areas of BIM with high analytical sensitivity. Next-generation sequencing panels for detection of TP53 and possibly combined mutations in other genes, such as APC and CDKN2A, may be useful in the clinical setting to improve dysplasia and cancer surveillance in patients with Barrett''s esophagus.CME Accreditation Statement: This activity (“JMD 2015 CME Program in Molecular Diagnostics”) has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Society for Clinical Pathology (ASCP) and the American Society for Investigative Pathology (ASIP). ASCP is accredited by the ACCME to provide continuing medical education for physicians.The ASCP designates this journal-based CME activity (“JMD 2015 CME Program in Molecular Diagnostics”) for a maximum of 36 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.CME Disclosures: The authors of this article and the planning committee members and staff have no relevant financial relationships with commercial interests to disclose.Esophageal adenocarcinoma (EAC) most frequently develops in patients with Barrett''s esophagus (BE), estimated to affect 3.3 million adults in the United States.1 BE results from injury of the esophageal mucosa associated with gastroesophageal reflux, which leads to esophagitis and eventually BE. The incidence of EAC has increased greater than fivefold during the past 4 decades in the United States, paralleling the increase in detection of esophageal reflux and diagnosis of BE.2 Barrett’s intestinal metaplasia (BIM) is characterized by the replacement of normal squamous esophageal mucosa by columnar epithelium with intestinal metaplasia, often occurring in the background of patches of cardiac, oxyntic, or cardiooxyntic mucosa along the length of the BE. Patients with BE may sequentially progress to low-grade dysplasia, high-grade dysplasia (HGD), and eventually EAC. Patients with BE without dysplasia have a lower EAC risk (0.1% to 0.5% per patient-year) than those with high-grade dysplasia (6% to 19% per patient-year).3,4 Current guidelines for the prevention of EAC require repeat surveillance endoscopies with biopsies of the Barrett''s mucosa followed by pathological examination to detect BIM and dysplasia.4–6 Unfortunately, the detection of dysplasia is hampered by sampling errors and high interobserver diagnostic variability.7–10Known risk factors associated with EAC include male sex, older age, white race, hiatal hernia size, length of Barrett''s epithelium, smoking, and high body mass index.6 Recently, it was reported that persistence of BE negative for dysplasia over several endoscopic examinations identifies patients who are at low risk for development of EAC.11It has been hoped that surveillance could potentially be improved by the implementation of risk stratification protocols using both clinical and biological markers because management of BE is costly and inefficient because only a small percentage of patients with BE progress to HGD or EAC.12 Furthermore, recent data revealed that endoscopic surveillance of patients with BE was not associated with a substantially decreased risk of death from EAC.13Biomarkers that can be assessed in random biopsy specimens from Barrett''s mucosa negative for dysplasia with the ability to predict development or concurrent (co-existing) dysplasia elsewhere in the esophagus are warranted to improve surveillance approaches in the BE population. Previously evaluated testing approaches for EAC risk stratification in BE using esophageal biopsy samples include nuclear DNA content abnormalities, such as aneuploidy and tetraploidy; gene copy number alterations, such as loss of heterozygosity of p16 (CDKN2A) and p53 (TP53)14,15; somatic gene mutations; and hypermethylation of a number of genes.14,16,17 However, published studies used fresh or frozen tissue or special sampling procedures, which limits their clinical implementation, and data from studies using routine formalin-fixed, paraffin-embedded (FFPE) clinical endoscopic samples replicating the clinical setting of BE patients undergoing endoscopic surveillance have not been reported.6Next-generation sequencing (NGS) approaches using nucleic acids obtained from routinely processed FFPE tissues to detect mutations in cancer samples, enabling high analytical sensitivity and detection of low-frequency mutational events, are well established. However, NGS testing of preneoplastic tissues, such as BE, have not been evaluated in routine FFPE clinical samples, and there is no information regarding the minimal percentage of intestinal metaplasis in the tested mucosal tissue that may be considered for mutation testing. Therefore, we hypothesized that targeted NGS may be ideally suited for clinical application in the BE surveillance setting because it can be performed with minimal amounts of DNA from routine FFPE tissue samples, permits biomarker multiplexing, and can reach high sensitivity to detect low-frequency mutational events in heterogeneous BE tissues, where the foci of intestinal metaplasia may be small. Sensitivity of mutation detection by NGS can be 0.5% or lower due to the high level of sequencing coverage, reaching several thousand reads per amplicon when targeted sequencing is used. Therefore, targeted NGS of BE FFPE samples enables the characterization of the mutational status of hundreds to thousands of target functional sites in oncogenes and tumor suppressor genes that may be critical in BE, dysplastic precursor lesions, and EAC in individual biopsy samples collected in the clinical diagnostic setting.We used two NGS-targeted amplicon sequencing technology platforms, the Illumina (San Diego, CA) TruSeq Cancer Panel for Illumina MiSeq platform and the Ion Torrent Ion AmpliSeq Cancer Panel (Life Technologies, Carlsbad, CA), to determine whether mutations of genes known to undergo mutagenesis in esophageal dysplasia or cancer arising in BE could predict the presence of HGD or EAC through testing random nondysplastic or noncancer BE mucosa with intestinal metaplasia using endoscopic FFPE samples. 相似文献
1000.
Primary refractory and early‐relapsed Hodgkin's lymphoma: strategies for therapeutic targeting based on the tumour microenvironment 下载免费PDF全文
Antonino Carbone Annunziata Gloghini Luca Castagna Armando Santoro Carmelo Carlo‐Stella 《The Journal of pathology》2015,237(1):4-13
Classical Hodgkin's lymphoma (cHL), a distinct disease entity with characteristic clinical and pathological features, accounts for approximately 10% of all malignant lymphomas. cHL can be considered a prototype model for how the tumour microenvironment influences cancer pathogenesis. Cellular components of the cHL microenvironment express molecules involved in cancer cell growth and survival, such as CD30L or CD40L. Moreover, several signal transduction pathways that are critical for the proliferation and survival of neoplastic Hodgkin Reed–Sternberg (HRS) cells, including NF‐κB, JAK–STAT, PI3K–AkT and ERK, are deregulated in cHL. Although most patients can be cured with modern treatment strategies, approximately a quarter experience either primary or secondary chemorefractoriness or disease relapse, thus requiring novel treatments. Preclinical and clinical evidence has elucidated a complex crosstalk between malignant HRS cells and the reactive cells of the microenvironment, which suggests that novel therapeutic approaches capable of targeting HRS cells along with reactive cells might overcome chemorefractoriness. In the near future, these novel therapies will also be tested in chemosensitive patients, to reduce the long‐term toxicity of chemo‐radiotherapy. Copyright © 2015 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. 相似文献